saba glp 1 GLP-1 INJECTIONS OR TABLETS Beyond the GLP-1RA weight loss

See recent WSJ article here Enthusiasts (biohackers?) and some longevity-focused clinicians believe that microdosing these drugs offers benefits beyond weight loss, such as improved metabolic health, glycemic control, reduced systemic inflammation, and potentially even a lower risk of age-related diseases

Weight-related conditions (tied to other diagnoses): Semaglutide may qualify when excess weight contributes to conditions such as high blood pressure, sleep apnea, or cardiovascular risk

However, allulose does not guarantee weight loss

[22] Management decisions depend on findings and symptom severity

Smaller, structured meals are your friend here

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis